STOCK TITAN
  1. Home
  2. News
  3. BDPT

Bioadaptives Inc - BDPT STOCK NEWS

Welcome to our dedicated news page for Bioadaptives (Ticker: BDPT), a resource for investors and traders seeking the latest updates and insights on Bioadaptives.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bioadaptives's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bioadaptives's position in the market.

News
BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
Rhea-AI Summary
BioAdaptives, Inc. (BDPT) introduces NaturaComplete™, an All-In-One Dietary Supplement formula containing over 70 nutrients to support general health and obesity management. The formula aims to provide bioavailable nutrients, protein building blocks, and promote immune defense and healing. It is designed to enhance body appearance by reducing body fat mass and addressing issues like muscle loss and hair loss.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
News
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
Rhea-AI Summary
BioAdaptives, Inc. (BDPT) announces a new, Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Loss Reported with Obesity Management. The app offers immediate, cost-effective, personalized assessments of body fat and muscle mass, along with tracking capabilities that can support any obesity or fitness regimen. The rising popularity of GLP-1 medications for treating obesity has spurred significant advancements in the development of more efficacious drugs and supplements. However, further studies are necessary to ascertain the potential side effects of these novel medications. The app enables users to conveniently monitor their body fat and muscle mass metrics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-38.46%
Tags
AI
-
News
BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System
Rhea-AI Summary
BioAdaptives, Inc. (BDPT) has signed a new non-exclusive Distributor’s Agreement with Pixelcando S.L., Tenerife, Spain, for the AI-supported FIT YOUR OUTFIT (FYO) body composition smartphone App. The agreement allows BioAdaptives to market the technology in the US directly to retail individual clients and organizations such as weight management/nutritional and fitness companies, sports teams, spas, health professionals, and senior communities. The FYO App utilizes AI to scientifically measure body composition with a single photo from a smartphone and provides advanced body composition analysis, progress monitoring, and is accompanied by the introduction of new health products for weight management, health, wellness, and fitness. The global body composition analyzer and weight loss app market is projected to grow to US$1.4 billion in 2027 and to US$2.6 billion by 2030.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
AI
News
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products
Rhea-AI Summary
BioAdaptives Inc. (BDPT) launches a specialized R&D Food Lab to create natural powder products and treats for animal and human consumption. The new facility aims to support holistic health solutions and the weight management AI BodyShape Division. The Food Lab will focus on developing high-quality, natural powder supplement formulations utilizing Traditional Chinese Medicine and Ayurvedic Culture ingredients. The company aims to expand its product line and provide accessible nutrition options for everyone in the family, including pets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management
Rhea-AI Summary
BioAdaptives Inc. (OTC: BDPT) announces the formation of a new business division, AI BodyShape Lab, in January 2024 to promote adult fitness and weight management. The division will optimize BioAdaptives’ patented, AI-based ‘Fit Your Outfit’ smartphone application and provide dietary information, suggested meal replacements, and exercises for adults. The CEO, Edward Jacobs, M.D., emphasizes the importance of identifying deep, internal, abdominal fat and its impact on overall body shape and health conditions like diabetes and cardiovascular disease. The new division aims to provide education and comprehensive services to support a healthier lifestyle.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
News
BioAdaptives, Inc. Introduces PROTEINnMORETM Ahead of 2024 Launch of AI-based “Fit Your Outfit” app
Rhea-AI Summary
BioAdaptives Inc. (BDPT) announces the development of PROTEINnMORETM, a plant-based supplement designed to improve muscle growth and strength. The company anticipates launching the AI-based Body Composition Measuring app, Fit Your Outfit (FYO), in Q1 2024. PROTEINnMORETM contains blended, purified hemp and pea protein combined with spirulina and other ingredients to maximize gastrointestinal uptake and bioavailability of nutrients. The global protein supplements market size was valued at USD 20.47 billion in 2021, with an expected CAGR of 8.5% from 2021 to 2030. The U.S. was the largest market for protein supplements in the North American region, with total revenue of USD 8.44 billion in 2021.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
News
BioAdaptives Announces Special Holiday Wellness Offers and Gift
Rhea-AI Summary
BioAdaptives, Inc. (BDPT) introduces special Holiday promotion offering up to 25% off on all-natural dietary supplements, targeting general health and wellness, especially for seniors. The sale runs through December, with free shipping and a free Lung Cleanser™ device with every supplement purchase.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
none
-
News
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
Rhea-AI Summary
BioAdaptives, Inc. (OTC: BDPT) highlights the importance of liver support as experts predict a steady rise in chronic liver disease over the next 25 years. The company announces the development of VeganHepPlusTM, an all-natural, vegan supplement designed to promote liver detoxification and support healthy hepatic function. The supplement is formulated with natural ingredients derived from Traditional Chinese Medicine and Ayurvedic culture, known to be beneficial for liver health.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
none
-
News
BioAdaptives Highlights Continued Success of Popular LUNG ARMOR™ System as US Enters Flu Season
Rhea-AI Summary
BDPT - BioAdaptives, Inc. Highlights LUNG ARMOR™ System Amid Rising COVID-19, RSV, and Influenza Hospitalizations. The company's unique combination of technologies promotes effortless breathing and robust, healthy lungs, addressing the increased risk of complications from the flu and other respiratory illnesses. The global respiratory care devices market is projected to reach $31.8 billion by 2028, indicating significant growth potential for BioAdaptives' products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
News
BioAdaptives Takes Aim at Safe Pain Management with All-Natural Supplement
Rhea-AI Summary
BioAdaptives, Inc. discusses its PluriPainⓇ pain relief supplement as the World Institute of Pain concludes its 12th World Congress in Turkey. Chronic pain affects an estimated 1.5 billion people worldwide, costing $55 billion in lost productivity in the US alone. BioAdaptives' supplement is plant-based, non-addictive, and includes ingredients like phycocyanin, hyaluronic acid, and MSM.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30%
Tags
none
Stock BDPT logo
Bioadaptives Inc

OTC:BDPT

BDPT Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

BDPT Stock Data

486.08k
970.36M
3.08%
Packaged Foods
Consumer Defensive
Link
United States
Las Vegas

About BDPT

bioadaptives is a research, development, and educational company. bioadaptives, inc. pursues nutraceutical research and development. we are making strides toward supplying solutions demanded by an increasingly aware population worldwide. we are a development stage company building a base of intellectual property and products that are patent pending and in demand in today’s market place. bioadaptives™ provides solutions in the form of nutraceuticals designed to aid in cognition, focus, fatigue reduction, increased testosterone, improved overall emotional and physical wellness, healing, and anti-aging.